Skip to main content
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. — Investor Relations & Filings

Ticker · PRAX ISIN · US74006W2070 US Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2020-10-16 Director's Dealing
Country US United States of America
Listing US PRAX

About Praxis Precision Medicines, Inc.

https://praxismedicines.com/

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2020-10-16 English
FORM 3 SUBMISSION
Director's Dealing
2020-10-16 English
FORM 3 SUBMISSION
Director's Dealing
2020-10-16 English
Regulatory Filings 2020
Regulatory Filings
2020-10-15 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter responding to comments from the SEC staff regarding an Amendment No. 1 to a Registration Statement on Form S-1. It discusses revisions to the Registration Statement and filing of a revised legal opinion exhibit. The document is correspondence related to a regulatory filing process, specifically an amendment to a registration statement for securities offering. It is not the registration statement itself, nor a financial report, but a regulatory correspondence letter. Given the nature and length (2033 characters), it is not a full report but a regulatory filing communication. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-10-15 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A Registration Statement filed with the SEC, which is used for registering securities for an initial public offering (IPO). It includes detailed information about the company, the offering, risk factors, financial data, management discussion, and other disclosures typical of a registration statement prospectus. This is not an annual report, earnings release, or any other type of financial report but a capital markets filing related to the company's IPO process. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement amendment, not a brief announcement or certification.
2020-10-15 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.